263 related articles for article (PubMed ID: 23536560)
1. Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.
Wilkie KP; Hahnfeldt P
Cancer Res; 2013 Jun; 73(12):3534-44. PubMed ID: 23536560
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of the cell-mediated immune response to tumour growth.
López ÁG; Seoane JM; Sanjuán MAF
Philos Trans A Math Phys Eng Sci; 2017 Jun; 375(2096):. PubMed ID: 28507236
[TBL] [Abstract][Full Text] [Related]
3. A review of mathematical models of cancer-immune interactions in the context of tumor dormancy.
Wilkie KP
Adv Exp Med Biol; 2013; 734():201-34. PubMed ID: 23143981
[TBL] [Abstract][Full Text] [Related]
4. Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma.
Wu X; Peng M; Huang B; Zhang H; Wang H; Huang B; Xue Z; Zhang L; Da Y; Yang D; Yao Z; Zhang R
Cancer Lett; 2013 Oct; 340(1):124-33. PubMed ID: 23920127
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted kinetics of immuno-evasion from tumor dormancy.
d'Onofrio A
Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
[TBL] [Abstract][Full Text] [Related]
6. [Dormancy of tumor cells].
Strien L; Joensuu K; Heikkilä P
Duodecim; 2013; 129(21):2245-52. PubMed ID: 24340675
[TBL] [Abstract][Full Text] [Related]
7. A mathematical model for the immune-mediated theory of metastasis.
Rhodes A; Hillen T
J Theor Biol; 2019 Dec; 482():109999. PubMed ID: 31493486
[TBL] [Abstract][Full Text] [Related]
8. A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity.
Alvarez RF; Barbuto JAM; Venegeroles R
J Theor Biol; 2019 Jun; 471():42-50. PubMed ID: 30930063
[TBL] [Abstract][Full Text] [Related]
9. The tumor microenvironment and its role in promoting tumor growth.
Whiteside TL
Oncogene; 2008 Oct; 27(45):5904-12. PubMed ID: 18836471
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
11. Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.
Payne KK; Keim RC; Graham L; Idowu MO; Wan W; Wang XY; Toor AA; Bear HD; Manjili MH
J Leukoc Biol; 2016 Sep; 100(3):625-35. PubMed ID: 26928306
[TBL] [Abstract][Full Text] [Related]
12. Evasion of tumours from the control of the immune system: consequences of brief encounters.
Al-Tameemi M; Chaplain M; d'Onofrio A
Biol Direct; 2012 Sep; 7():31. PubMed ID: 23009638
[TBL] [Abstract][Full Text] [Related]
13. Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?
Kareva I; Luddy KA; O'Farrelly C; Gatenby RA; Brown JS
Front Immunol; 2021; 12():668221. PubMed ID: 34531851
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer.
Ferguson LP; Diaz E; Reya T
Trends Cancer; 2021 Jul; 7(7):624-634. PubMed ID: 33509688
[TBL] [Abstract][Full Text] [Related]
15. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
Yang L; Li A; Lei Q; Zhang Y
J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
17. Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy.
Eltoukhy HS; Sinha G; Moore CA; Sandiford OA; Rameshwar P
Cell Immunol; 2018 Apr; 326():33-41. PubMed ID: 28779846
[TBL] [Abstract][Full Text] [Related]
18. Eph Receptors in the Immunosuppressive Tumor Microenvironment.
Janes PW; Vail ME; Ernst M; Scott AM
Cancer Res; 2021 Feb; 81(4):801-805. PubMed ID: 33177063
[TBL] [Abstract][Full Text] [Related]
19. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
20. Immunological-based approaches for cancer therapy.
Barros L; Pretti MA; Chicaybam L; Abdo L; Boroni M; Bonamino MH
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e429s. PubMed ID: 30133560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
